Skip to main content

Closed

NKTR: Nektar Therapeutics Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-224.9%

ROIC-17.2%

Financially safe

Stretched

Debt / equity0.25×

Interest coverage-4.3×

Current ratio10.21×

Nektar Therapeutics

NKTRNASDAQ Global Select·USD·Closed

Nektar Therapeutics

NKTRNASDAQ·USD·Closed

$70.67

−1.09%

$70.67

−$0.78 (1.09%)

52W Range

56thpctl

Volume

0.47×avg

Mkt Cap

1.38BUSD

P/E

-8.4TTM

Div Yield

–ann

52W Range

56thpctl

Volume

0.47×avg

Market Cap

1.38BUSD

P/E Ratio

-8.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings